News in brief

Pii to double sterile capacity in Maryland site expansion

Pharmaceutics International, Inc (Pii) is to double its sterile GMP production capacity by building a 24,000 sq ft facility.

Construction of the facility in Maryland, US will strengthen Pii in the growth areas of oncology and high potency compounds by giving it more fill/finish suites for handling vials and syringes.

“The additional facilities will enable us to support our clients from pre-clinical through commercial-scale production and meet the growing demand for fill/finish services for potent compounds and oncology drugs”, Steve King, senior vice president of Pii, said.

Pii expects to complete construction of the facility in the fourth quarter of 2012.

This content is copyright protected

However, if you would like to share the information in this article, you may use the headline, summary and link below: